海納智能(01645.HK)預期中期淨利同比減少不多於30%
格隆匯8月10日丨海納智能(01645.HK)公吿,相比2020年同期公司擁有人應占未經審核綜合純利人民幣約2460萬元,集團預期截至2021年6月30日止6個月公司擁有人應占綜合純利將錄得不多於30%減幅,主要由於隨着新型冠狀病毒病疫情影響消退,中國恢復常態,導致一次性醫用口罩機器需求減少,且集團於截至2021年6月30日止6個月並無售出一次性醫用口罩機器,而於截至2020年6月30日止6個月則售出201台一次性醫用口罩機器。
有關減幅影響部分被截至2021年6月30日止6個月來自銷售嬰兒紙尿褲、成人紙尿褲、女性衞生巾及護墊機器收益增加所抵銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.